Union Springs Pharmaceuticals, LLC today announced the European distribution of its flagship product, MyClyns, a portable spray that is designed to eliminate 99.99 percent of many harmful pathogens and help prevent infection. European first responders and public safety officials will now have access to the spray, which is a critical component to effective, portable protection.
MyClyns is available from a number of distributors throughout Europe.
After coming into contact with bodily fluids from a potentially infected person, first responders can quickly and easily spray MyClyns in their eyes, mouth or on other points of contact. Response time is critical to lower the chances of becoming infected after an exposure, and MyClyns offers immediate protection.
The pocket-sized units contain a powerful solution that has been found to reduce 99.99 percent of HIV-1, hepatitis C, MRSA, TB, and 60 pathogens in independent laboratory testing. The spray is alcohol-free and proven safe for use on all mucous membranes, including the eyes, ears, nose, and mouth.
"MyClyns has found significant success within the public safety sector, as first responders are frequently exposed to the dangers of bodily fluids and other harmful pathogens," says Union Springs Pharmaceuticals president Joel Ivers. "The expansion of this product into European markets is in response to the need for personal protection anywhere in the world where public safety officials risk dangerous exposure."
The spray has already proven to be an asset to public safety officials, military, corrections, and EMS in the United States and Canada.
New Orleans EMS deputy director Carl Flores agrees. "One of our employees had a combative patient who was HIV positive spit in his face," said Flores. "He used MyClyns and felt better knowing it was readily available for this incident. As a manager, I cannot tell you how pleased I am to provide our employees with this added layer of protection and sense of confidence when they needed it most."
Visit http://www.myclyns.eu for more information about the product.
Source: Union Springs Pharmaceuticals, LLC